.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Extended Adjuvant Endocrine Therapy: The Role of Genomic Profiling

EP. 1: Treatment for Early-Stage ER+ Breast Cancer

October 24th 2016

EP. 2: MA.17R Trial Data Results

October 24th 2016

EP. 3: MA.17R Trial Data Effect on Treatment of ER+ Disease

October 24th 2016

EP. 4: Risk of Early Versus Late Recurrence

October 24th 2016

EP. 5: Extended Aromatase Inhibitor Risk/Benefit

October 24th 2016

EP. 6: QOL Analysis of MA.17R and Treatment Decisions

October 24th 2016

EP. 7: Genomic Testing for Risk of Late Recurrence/ASCO Guidelines

October 24th 2016

EP. 8: Types of Genomic Testing

October 24th 2016

EP. 9: Benefits of Genomic Testing in Breast Cancer

October 24th 2016